查看購物車
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1942761

2026年全球藥物輸注系統市場報告

Drug Infusion Systems Global Market Report 2026
出版日期: | 出版商: The Business Research Company | 英文 250 Pages | 商品交期: 2-10個工作天內

價格
簡介目錄

近年來，輸液系統市場成長顯著，預計到2025年將達到142.3億美元，到2026年將達到155.1億美元，複合年成長率為9.0%。過去幾年的成長歸因於住院率上升、慢性病盛行率上升、腫瘤和化療的擴展、靜脈給藥使用量的增加以及輸液技術的日益普及。

預計未來幾年，藥物輸注系統市場將維持強勁成長，2030年市場規模將達到222.3億美元，複合年成長率（CAGR）為9.4%。預測期內的成長主要歸功於互聯輸注系統的日益普及、門診和居家醫療對輸註解決方案需求的不斷成長、精準給藥方式的推廣、醫院對工作流程自動化的日益重視以及對智慧醫療基礎設施投資的增加。預測期內的關鍵趨勢包括智慧輸注幫浦的日益普及、系統整合度的提高以減少給藥誤差、多通道輸注設備的廣泛應用、家庭輸注治療的成長以及對患者安全功能的日益重視。

預計未來醫療保健支出的成長將推動輸液系統市場的發展。醫療保健支出是指在特定時期（通常為一年）內用於醫療產品和服務的總金額。隨著醫療保健支出的增加，醫院、診所和其他醫療機構可以增加對先進輸液系統的投資，從而增加對這些設備的需求。例如，根據英國國家統計局 (ONS) 2024 年 5 月發布的報告，2022 年至 2023 年，醫療保健總支出名目成長率為 5.6%，遠高於 2022 年 0.9% 的成長率。因此，醫療保健支出的成長很可能推動輸液系統市場的成長。

輸液系統市場的主要企業正致力於開發先進技術，例如基於雲端的輸液管理系統，以改善患者照護、提高準確性並簡化輸液治療的管理。基於雲端的輸液管理系統是能夠透過雲端監測、管理和追蹤藥物輸注的數位化平台。例如，2023年6月，總部位於美國的全球領先先進輸液治療和藥物輸送解決方案提供商Eitan Medical推出了Eitan Insights，這是一款全新的基於雲端的輸液管理系統，旨在滿足家庭和特殊輸液的特定需求。 Eitan Insights為醫療專業人員提供即時數據和分析，從而實現遠端病患監測並根據需要調整治療方案。該系統透過最大限度地降低給藥錯誤風險和提高處方通訊協定的依從性來增強用藥安全性。

目錄

第1章執行摘要

第2章 市場特徵

  • 市場定義和範圍
  • 市場區隔
  • 主要產品和服務概述
  • 全球輸液系統市場：吸引力評分及分析
  • 成長潛力分析、競爭評估、策略契合度評估、風險狀況評估

第3章 市場供應鏈分析

  • 供應鏈與生態系概述
  • 主要原料、資源和供應商清單
  • 主要經銷商和通路合作夥伴名單
  • 主要最終用戶列表

第4章 全球市場趨勢與策略

  • 關鍵技術和未來趨勢
    • 人工智慧（AI）和自主人工智慧
    • 物聯網、智慧基礎設施和互聯生態系統
    • 數位化、雲端運算、巨量資料、網路安全
    • 工業4.0和智慧製造
    • 生物技術、基因組學和精準醫學
  • 主要趨勢
    • 智慧型輸液幫浦的廣泛應用
    • 劑量誤差減少系統整合進展
    • 多通道輸液裝置的應用日益廣泛
    • 擴大家庭輸液治療
    • 更加重視病患安全功能

第5章 終端用戶產業市場分析

  • 醫院
  • 門診手術中心
  • 診斷中心
  • 居家醫療保健服務提供者
  • 專科診所

第6章 市場：宏觀經濟情景，包括利率、通貨膨脹、地緣政治、貿易戰和關稅的影響、關稅戰和貿易保護主義對供應鏈的影響，以及新冠疫情對市場的影響

第7章 全球策略分析架構、目前市場規模、市場對比及成長率分析

  • 全球輸液系統市場：PESTEL 分析（政治、社會、技術、環境、法律因素、促進因素與限制因素）
  • 全球輸液系統市場規模、對比及成長率分析
  • 全球輸液系統市場表現：規模與成長，2020-2025年
  • 全球輸液系統市場預測：規模與成長，2025-2030年，2035年預測

第8章 全球潛在市場規模（TAM）

第9章 市場細分

  • 依產品類型
  • 彈性體輸液系統、一次性輸液系統、注射器輸液系統、蠕動幫浦、多通道幫浦、病人自控式止痛（PCA）幫浦、胰島素幫浦、植入式輸液系統
  • 透過行政途徑
  • 靜脈注射、皮下注射、動脈注射、硬脊膜外注射及其他給藥途徑
  • 透過使用
  • 腫瘤學和化療、糖尿病、疼痛緩解、營養、血液學、小兒科及其他用途
  • 最終用戶
  • 醫院、門診手術中心、診斷中心和其他最終用戶
  • 依類型細分：彈性體注塑系統
  • 無排氣彈性體泵，排氣彈性體泵
  • 按類型細分：一次性輸液系統
  • 一次性輸液泵，含一次性零件的靜脈輸液器
  • 按類型細分：注射器注射系統
  • 手動注射泵，電動注射泵
  • 按類型細分：蠕動泵
  • 單通道蠕動泵，多通道蠕動泵
  • 按類型細分：多通道泵
  • 通用型多通道輸液泵，用於特定治療的多通道輸液泵
  • 按類型細分：患者自控鎮痛（PCA）泵
  • 電子式PCA泵，機械式PCA泵
  • 按類型細分：胰島素泵
  • 持續皮下胰島素輸注（CSII）幫浦、貼片式胰島素幫浦
  • 按類型細分：植入式輸液系統
  • 用於治療慢性疼痛的植入式泵，用於化療的植入式泵

第10章 區域與國家分析

  • 全球輸液系統市場：區域分析、預測與趨勢，2020-2025年、2025-2030年預測、2035年預測
  • 全球輸液系統市場：依國家、績效及預測分類，2020-2025年、2025-2030年預測、2035年預測

第11章 亞太市場

第12章：中國市場

第13章 印度市場

第14章 日本市場

第15章：澳洲市場

第16章 印尼市場

第17章 韓國市場

第18章 台灣市場

第19章 東南亞市場

第20章：西歐市場

第21章英國市場

第22章 德國市場

第23章：法國市場

第24章：義大利市場

第25章：西班牙市場

第26章 東歐市場

第27章：俄羅斯市場

第28章 北美市場

第29章：美國市場

第30章：加拿大市場

第31章 南美洲市場

第32章：巴西市場

第33章 中東市場

第34章：非洲市場

第35章 市場監理與投資環境

第36章：競爭格局與公司概況

  • 藥物輸注系統市場：競爭格局及市場佔有率（2024年）
  • 藥物輸注系統市場：公司估值矩陣
  • 藥物輸注系統市場：公司概況
    • Medtronic plc
    • Baxter International Inc.
    • B. Braun Melsungen AG
    • Becton, Dickinson and Company
    • Smiths Group plc

第37章：其他領先和創新企業

  • Terumo Corporation, Fresenius SE & Co. KGaA, ICU Medical Inc., Tandem Diabetes Care Inc., Insulet Corporation, Ypsomed Holding AG, Abbott Diabetes Care Inc., Flowonix Medical Inc., Zyno Medical Inc., IRadimed Corporation, Debiotech SA, Valeritas Inc., Disetronic Medical Systems AG, Alaris Health Systems Inc., Hospira Inc.

第38章 全球市場競爭基準分析與儀錶板

第39章 重大併購

第40章：高潛力市場國家、細分市場與策略

  • 2030年藥物輸注系統市場：提供新機會的國家
  • 2030年藥物輸注系統市場：新興細分市場機會
  • 2030年藥物輸注系統市場：成長策略
    • 基於市場趨勢的策略
    • 競爭對手策略

第41章附錄

簡介目錄
Product Code: ME4MDISN01_G26Q1

Drug infusion systems, classified as medical devices, are instrumental in delivering medications and fluids into a patient's body through a catheter or needle. This method of administration is commonly employed in hospitals, clinics, and various healthcare settings to dispense medications such as pain relievers, antibiotics, chemotherapy drugs, and fluids to patients.

The primary categories of drug infusion systems encompass elastomeric infusion systems, disposable infusion systems, syringe infusion systems, peristaltic pumps, multi-channel pumps, patient-controlled analgesia (PCA) pumps, insulin pumps, and implantable infusion systems. Elastomeric infusion systems, for instance, are flexible containers designed to provide a consistent rate of medication delivery for short-term infusion therapy. They find application in hospitals, clinics, and home care settings for short-term drug infusion therapy. These systems are versatile, administered through various modes such as intravenous, subcutaneous, arterially, epidurally, and others. They cater to diverse medical applications, including oncology and chemotherapy, diabetes, analgesia, nutrition, hematology, pediatrics, and more. Various end-users, such as hospitals, ambulatory surgical centers, diagnostic centers, and others, utilize elastomeric infusion systems for their respective needs.

Tariffs are impacting the drug infusion systems market by increasing costs of imported electronic components, sensors, precision pumps, and medical-grade plastics used in infusion devices. Hospitals and healthcare providers in North America and Europe are most affected due to reliance on imported components, while Asia-Pacific faces pricing pressure on device manufacturing and exports. These tariffs are contributing to higher device procurement costs and delayed equipment upgrades. However, they are also encouraging localized manufacturing, regional supplier diversification, and increased investments in domestic medical device production capabilities.

The drug infusion systems market research report is one of a series of new reports from The Business Research Company that provides drug infusion systems market statistics, including drug infusion systems industry global market size, regional shares, competitors with a drug infusion systems market share, detailed drug infusion systems market segments, market trends and opportunities, and any further data you may need to thrive in the drug infusion systems industry. This drug infusion systems market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The drug infusion systems market size has grown strongly in recent years. It will grow from $14.23 billion in 2025 to $15.51 billion in 2026 at a compound annual growth rate (CAGR) of 9.0%. The growth in the historic period can be attributed to increasing hospitalization rates, rising prevalence of chronic diseases, expansion of oncology and chemotherapy treatments, growing use of intravenous drug delivery, improved availability of infusion technologies.

The drug infusion systems market size is expected to see strong growth in the next few years. It will grow to $22.23 billion in 2030 at a compound annual growth rate (CAGR) of 9.4%. The growth in the forecast period can be attributed to increasing adoption of connected infusion systems, rising demand for ambulatory and homecare infusion solutions, expansion of precision drug delivery approaches, growing focus on workflow automation in hospitals, increasing investments in smart healthcare infrastructure. Major trends in the forecast period include increasing adoption of smart infusion pumps, rising integration of dose error reduction systems, growing use of multi-channel infusion devices, expansion of home-based infusion therapies, enhanced focus on patient safety features.

The rise in healthcare expenditure is expected to drive the growth of the drug infusion systems market in the future. Healthcare expenditure refers to the total amount allocated for healthcare goods and services within a specific timeframe, usually a year. As healthcare spending increases, hospitals, clinics, and other healthcare institutions gain more resources to invest in advanced drug infusion systems, resulting in higher demand for these devices. For example, in May 2024, reports from the Office for National Statistics (ONS), a UK-based national statistical institute, indicated that total healthcare spending increased by 5.6% in nominal terms from 2022 to 2023, compared to a growth rate of only 0.9% in 2022. Therefore, the increase in healthcare expenditure is likely to propel the growth of the drug infusion systems market.

Leading companies in the drug infusion systems market are focusing on developing advanced technologies, such as cloud-based infusion management systems, to improve patient care, enhance accuracy, and streamline the management of infusion therapies. Cloud-based infusion management systems are digital platforms that enable the monitoring, administration, and tracking of medication infusions via the cloud. For example, in June 2023, Eitan Medical, a U.S.-based global leader in advanced infusion therapy and drug delivery solutions, launched Eitan Insights, a new cloud-based infusion management system tailored to meet the specific needs of home and specialty infusions. Eitan Insights provides healthcare professionals with real-time data and analytics, allowing them to monitor patients remotely and adjust treatment plans as necessary. This system enhances medication safety by minimizing the risk of errors and improving adherence to prescribed protocols.

In November 2025, Biogen Inc., a US-based biotechnology company, acquired Alcyone Therapeutics for an undisclosed amount. Through this acquisition, Biogen aims to enhance its drug-delivery capabilities by integrating Alcyone's ThecaFlex DRx implantable intrathecal system, improving patient experience and expanding access to its CNS therapies. Alcyone Therapeutics Inc., a US-based company, specializes in drug infusion systems.

Major companies operating in the drug infusion systems market are Medtronic plc, Baxter International Inc., B. Braun Melsungen AG, Becton Dickinson and Company, Smiths Group plc, Terumo Corporation, Fresenius SE & Co. KGaA, ICU Medical Inc., Tandem Diabetes Care Inc., Insulet Corporation, Ypsomed Holding AG, Abbott Diabetes Care Inc., Flowonix Medical Inc., Zyno Medical Inc., IRadimed Corporation, Debiotech S.A., Valeritas Inc., Disetronic Medical Systems AG, Alaris Health Systems Inc., Hospira Inc., Mindray Medical International Limited

North America was the largest region in the drug infusion systems market in 2025. Asia-Pacific is expected to be the fastest-growing region in the global drug infusion systems market report during the forecast period. The regions covered in the drug infusion systems market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the drug infusion systems market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain

The drug infusion systems market consists of sales of smart pumps, syringe pumps, enteral infusion systems, and topical infusion systems. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Drug Infusion Systems Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses drug infusion systems market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
  • Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on end user analysis.
  • Benchmark performance against key competitors based on market share, innovation, and brand strength.
  • Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
  • Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
  • Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for drug infusion systems ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The drug infusion systems market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
  • The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
  • The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
  • The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
  • The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
  • The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
  • Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.

Scope

  • Markets Covered:1) By Product Type: Elastomeric Infusion System; Disposable Infusion System; Syringe Infusion System; Peristaltic Pump; Multi-Channel Pump; Patient-Controlled Analgesia (PCA) Pump; Insulin Pump; Implantable Infusion System
  • 2) By Route Of Administration: Intravenous; Subcutaneous; Arterial; Epidural; Other Routes Of Administration
  • 3) By Application: Oncology And Chemotherapy; Diabetes; Analgesia; Nutrition; Hematology; Pediatrics; Other Applications
  • 4) By End User: Hospitals; Ambulatory Surgical Centers; Diagnostic Centers; Other End Users
  • Subsegments:
  • 1) By Elastomeric Infusion System: Non-Vented Elastomeric Pumps; Vented Elastomeric Pumps
  • 2) By Disposable Infusion System: Disposable Infusion Pumps; IV Sets With Disposable Components
  • 3) By Syringe Infusion System: Manual Syringe Infusion Pumps; Electric Syringe Infusion Pumps
  • 4) By Peristaltic Pump: Single-Channel Peristaltic Pumps; Multi-Channel Peristaltic Pumps
  • 5) By Multi-Channel Pump: Multi-Channel Infusion Pumps For General Use; Multi-Channel Pumps For Specific Therapies
  • 6) By Patient-Controlled Analgesia (PCA) Pump: Electronic PCA Pumps; Mechanical PCA Pumps
  • 7) By Insulin Pump: Continuous Subcutaneous Insulin Infusion (CSII) Pumps; Patch Insulin Pumps
  • 8) By Implantable Infusion System: Implantable Pumps For Chronic Pain; Implantable Pumps For Chemotherapy
  • Companies Mentioned: Medtronic plc; Baxter International Inc.; B. Braun Melsungen AG; Becton Dickinson and Company; Smiths Group plc; Terumo Corporation; Fresenius SE & Co. KGaA; ICU Medical Inc.; Tandem Diabetes Care Inc.; Insulet Corporation; Ypsomed Holding AG; Abbott Diabetes Care Inc.; Flowonix Medical Inc.; Zyno Medical Inc.; IRadimed Corporation; Debiotech S.A.; Valeritas Inc.; Disetronic Medical Systems AG; Alaris Health Systems Inc.; Hospira Inc.; Mindray Medical International Limited
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Taiwan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time Series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery Format: Word, PDF or Interactive Report
  • + Excel Dashboard
  • Added Benefits
  • Bi-Annual Data Update
  • Customisation
  • Expert Consultant Support

Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.

Table of Contents

1. Executive Summary

  • 1.1. Key Market Insights (2020-2035)
  • 1.2. Visual Dashboard: Market Size, Growth Rate, Hotspots
  • 1.3. Major Factors Driving the Market
  • 1.4. Top Three Trends Shaping the Market

2. Drug Infusion Systems Market Characteristics

  • 2.1. Market Definition & Scope
  • 2.2. Market Segmentations
  • 2.3. Overview of Key Products and Services
  • 2.4. Global Drug Infusion Systems Market Attractiveness Scoring And Analysis
    • 2.4.1. Overview of Market Attractiveness Framework
    • 2.4.2. Quantitative Scoring Methodology
    • 2.4.3. Factor-Wise Evaluation
  • Growth Potential Analysis, Competitive Dynamics Assessment, Strategic Fit Assessment And Risk Profile Evaluation
    • 2.4.4. Market Attractiveness Scoring and Interpretation
    • 2.4.5. Strategic Implications and Recommendations

3. Drug Infusion Systems Market Supply Chain Analysis

  • 3.1. Overview of the Supply Chain and Ecosystem
  • 3.2. List Of Key Raw Materials, Resources & Suppliers
  • 3.3. List Of Major Distributors and Channel Partners
  • 3.4. List Of Major End Users

4. Global Drug Infusion Systems Market Trends And Strategies

  • 4.1. Key Technologies & Future Trends
    • 4.1.1 Artificial Intelligence & Autonomous Intelligence
    • 4.1.2 Internet Of Things (Iot), Smart Infrastructure & Connected Ecosystems
    • 4.1.3 Digitalization, Cloud, Big Data & Cybersecurity
    • 4.1.4 Industry 4.0 & Intelligent Manufacturing
    • 4.1.5 Biotechnology, Genomics & Precision Medicine
  • 4.2. Major Trends
    • 4.2.1 Increasing Adoption Of Smart Infusion Pumps
    • 4.2.2 Rising Integration Of Dose Error Reduction Systems
    • 4.2.3 Growing Use Of Multi-Channel Infusion Devices
    • 4.2.4 Expansion Of Home-Based Infusion Therapies
    • 4.2.5 Enhanced Focus On Patient Safety Features

5. Drug Infusion Systems Market Analysis Of End Use Industries

  • 5.1 Hospitals
  • 5.2 Ambulatory Surgical Centers
  • 5.3 Diagnostic Centers
  • 5.4 Homecare Providers
  • 5.5 Specialty Clinics

6. Drug Infusion Systems Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, Supply Chain Impact from Tariff War & Trade Protectionism, And Covid And Recovery On The Market

7. Global Drug Infusion Systems Strategic Analysis Framework, Current Market Size, Market Comparisons And Growth Rate Analysis

  • 7.1. Global Drug Infusion Systems PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
  • 7.2. Global Drug Infusion Systems Market Size, Comparisons And Growth Rate Analysis
  • 7.3. Global Drug Infusion Systems Historic Market Size and Growth, 2020 - 2025, Value ($ Billion)
  • 7.4. Global Drug Infusion Systems Forecast Market Size and Growth, 2025 - 2030, 2035F, Value ($ Billion)

8. Global Drug Infusion Systems Total Addressable Market (TAM) Analysis for the Market

  • 8.1. Definition and Scope of Total Addressable Market (TAM)
  • 8.2. Methodology and Assumptions
  • 8.3. Global Total Addressable Market (TAM) Estimation
  • 8.4. TAM vs. Current Market Size Analysis
  • 8.5. Strategic Insights and Growth Opportunities from TAM Analysis

9. Drug Infusion Systems Market Segmentation

  • 9.1. Global Drug Infusion Systems Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Elastomeric Infusion System, Disposable Infusion System, Syringe Infusion System, Peristaltic Pump, Multi-Channel Pump, Patient-Controlled Analgesia (PCA) Pump, Insulin Pump, Implantable Infusion System
  • 9.2. Global Drug Infusion Systems Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Intravenous, Subcutaneous, Arterial, Epidural, Other Routes Of Administration
  • 9.3. Global Drug Infusion Systems Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Oncology And Chemotherapy, Diabetes, Analgesia, Nutrition, Hematology, Pediatrics, Other Applications
  • 9.4. Global Drug Infusion Systems Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Hospitals, Ambulatory Surgical Centers, Diagnostic Centers, Other End Users
  • 9.5. Global Drug Infusion Systems Market, Sub-Segmentation Of Elastomeric Infusion System, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Non-Vented Elastomeric Pumps, Vented Elastomeric Pumps
  • 9.6. Global Drug Infusion Systems Market, Sub-Segmentation Of Disposable Infusion System, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Disposable Infusion Pumps, IV Sets With Disposable Components
  • 9.7. Global Drug Infusion Systems Market, Sub-Segmentation Of Syringe Infusion System, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Manual Syringe Infusion Pumps, Electric Syringe Infusion Pumps
  • 9.8. Global Drug Infusion Systems Market, Sub-Segmentation Of Peristaltic Pump, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Single-Channel Peristaltic Pumps, Multi-Channel Peristaltic Pumps
  • 9.9. Global Drug Infusion Systems Market, Sub-Segmentation Of Multi-Channel Pump, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Multi-Channel Infusion Pumps For General Use, Multi-Channel Pumps For Specific Therapies
  • 9.10. Global Drug Infusion Systems Market, Sub-Segmentation Of Patient-Controlled Analgesia (PCA) Pump, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Electronic PCA Pumps, Mechanical PCA Pumps
  • 9.11. Global Drug Infusion Systems Market, Sub-Segmentation Of Insulin Pump, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Continuous Subcutaneous Insulin Infusion (CSII) Pumps, Patch Insulin Pumps
  • 9.12. Global Drug Infusion Systems Market, Sub-Segmentation Of Implantable Infusion System, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Implantable Pumps For Chronic Pain, Implantable Pumps For Chemotherapy

10. Drug Infusion Systems Market Regional And Country Analysis

  • 10.1. Global Drug Infusion Systems Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • 10.2. Global Drug Infusion Systems Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

11. Asia-Pacific Drug Infusion Systems Market

  • 11.1. Asia-Pacific Drug Infusion Systems Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 11.2. Asia-Pacific Drug Infusion Systems Market, Segmentation By Product Type, Segmentation By Route Of Administration, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

12. China Drug Infusion Systems Market

  • 12.1. China Drug Infusion Systems Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 12.2. China Drug Infusion Systems Market, Segmentation By Product Type, Segmentation By Route Of Administration, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

13. India Drug Infusion Systems Market

  • 13.1. India Drug Infusion Systems Market, Segmentation By Product Type, Segmentation By Route Of Administration, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

14. Japan Drug Infusion Systems Market

  • 14.1. Japan Drug Infusion Systems Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 14.2. Japan Drug Infusion Systems Market, Segmentation By Product Type, Segmentation By Route Of Administration, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

15. Australia Drug Infusion Systems Market

  • 15.1. Australia Drug Infusion Systems Market, Segmentation By Product Type, Segmentation By Route Of Administration, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

16. Indonesia Drug Infusion Systems Market

  • 16.1. Indonesia Drug Infusion Systems Market, Segmentation By Product Type, Segmentation By Route Of Administration, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

17. South Korea Drug Infusion Systems Market

  • 17.1. South Korea Drug Infusion Systems Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 17.2. South Korea Drug Infusion Systems Market, Segmentation By Product Type, Segmentation By Route Of Administration, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

18. Taiwan Drug Infusion Systems Market

  • 18.1. Taiwan Drug Infusion Systems Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 18.2. Taiwan Drug Infusion Systems Market, Segmentation By Product Type, Segmentation By Route Of Administration, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

19. South East Asia Drug Infusion Systems Market

  • 19.1. South East Asia Drug Infusion Systems Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 19.2. South East Asia Drug Infusion Systems Market, Segmentation By Product Type, Segmentation By Route Of Administration, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

20. Western Europe Drug Infusion Systems Market

  • 20.1. Western Europe Drug Infusion Systems Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 20.2. Western Europe Drug Infusion Systems Market, Segmentation By Product Type, Segmentation By Route Of Administration, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

21. UK Drug Infusion Systems Market

  • 21.1. UK Drug Infusion Systems Market, Segmentation By Product Type, Segmentation By Route Of Administration, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

22. Germany Drug Infusion Systems Market

  • 22.1. Germany Drug Infusion Systems Market, Segmentation By Product Type, Segmentation By Route Of Administration, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

23. France Drug Infusion Systems Market

  • 23.1. France Drug Infusion Systems Market, Segmentation By Product Type, Segmentation By Route Of Administration, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

24. Italy Drug Infusion Systems Market

  • 24.1. Italy Drug Infusion Systems Market, Segmentation By Product Type, Segmentation By Route Of Administration, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

25. Spain Drug Infusion Systems Market

  • 25.1. Spain Drug Infusion Systems Market, Segmentation By Product Type, Segmentation By Route Of Administration, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

26. Eastern Europe Drug Infusion Systems Market

  • 26.1. Eastern Europe Drug Infusion Systems Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 26.2. Eastern Europe Drug Infusion Systems Market, Segmentation By Product Type, Segmentation By Route Of Administration, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

27. Russia Drug Infusion Systems Market

  • 27.1. Russia Drug Infusion Systems Market, Segmentation By Product Type, Segmentation By Route Of Administration, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

28. North America Drug Infusion Systems Market

  • 28.1. North America Drug Infusion Systems Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 28.2. North America Drug Infusion Systems Market, Segmentation By Product Type, Segmentation By Route Of Administration, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

29. USA Drug Infusion Systems Market

  • 29.1. USA Drug Infusion Systems Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 29.2. USA Drug Infusion Systems Market, Segmentation By Product Type, Segmentation By Route Of Administration, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

30. Canada Drug Infusion Systems Market

  • 30.1. Canada Drug Infusion Systems Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 30.2. Canada Drug Infusion Systems Market, Segmentation By Product Type, Segmentation By Route Of Administration, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

31. South America Drug Infusion Systems Market

  • 31.1. South America Drug Infusion Systems Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 31.2. South America Drug Infusion Systems Market, Segmentation By Product Type, Segmentation By Route Of Administration, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

32. Brazil Drug Infusion Systems Market

  • 32.1. Brazil Drug Infusion Systems Market, Segmentation By Product Type, Segmentation By Route Of Administration, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

33. Middle East Drug Infusion Systems Market

  • 33.1. Middle East Drug Infusion Systems Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 33.2. Middle East Drug Infusion Systems Market, Segmentation By Product Type, Segmentation By Route Of Administration, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

34. Africa Drug Infusion Systems Market

  • 34.1. Africa Drug Infusion Systems Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 34.2. Africa Drug Infusion Systems Market, Segmentation By Product Type, Segmentation By Route Of Administration, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

35. Drug Infusion Systems Market Regulatory and Investment Landscape

36. Drug Infusion Systems Market Competitive Landscape And Company Profiles

  • 36.1. Drug Infusion Systems Market Competitive Landscape And Market Share 2024
    • 36.1.1. Top 10 Companies (Ranked by revenue/share)
  • 36.2. Drug Infusion Systems Market - Company Scoring Matrix
    • 36.2.1. Market Revenues
    • 36.2.2. Product Innovation Score
    • 36.2.3. Brand Recognition
  • 36.3. Drug Infusion Systems Market Company Profiles
    • 36.3.1. Medtronic plc Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.2. Baxter International Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.3. B. Braun Melsungen AG Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.4. Becton, Dickinson and Company Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.5. Smiths Group plc Overview, Products and Services, Strategy and Financial Analysis

37. Drug Infusion Systems Market Other Major And Innovative Companies

  • Terumo Corporation, Fresenius SE & Co. KGaA, ICU Medical Inc., Tandem Diabetes Care Inc., Insulet Corporation, Ypsomed Holding AG, Abbott Diabetes Care Inc., Flowonix Medical Inc., Zyno Medical Inc., IRadimed Corporation, Debiotech S.A., Valeritas Inc., Disetronic Medical Systems AG, Alaris Health Systems Inc., Hospira Inc.

38. Global Drug Infusion Systems Market Competitive Benchmarking And Dashboard

39. Key Mergers And Acquisitions In The Drug Infusion Systems Market

40. Drug Infusion Systems Market High Potential Countries, Segments and Strategies

  • 40.1 Drug Infusion Systems Market In 2030 - Countries Offering Most New Opportunities
  • 40.2 Drug Infusion Systems Market In 2030 - Segments Offering Most New Opportunities
  • 40.3 Drug Infusion Systems Market In 2030 - Growth Strategies
    • 40.3.1 Market Trend Based Strategies
    • 40.3.2 Competitor Strategies

41. Appendix

  • 41.1. Abbreviations
  • 41.2. Currencies
  • 41.3. Historic And Forecast Inflation Rates
  • 41.4. Research Inquiries
  • 41.5. The Business Research Company
  • 41.6. Copyright And Disclaimer